探索运动衍生的细胞外囊在癌症生物学中的影响
Monica Silvestri1, Elisa Grazioli2, Guglielmo Duranti3
1Unit of Biology and Genetics of Movement, Department of Movement, Human and Health Sciences, University of Rome Foro Italico, 00135 Rome, Italy.
Biology
|September 28, 2024
概括
运动衍生的细胞外囊泡 (EVs) 通过抑制瘤生长和增强治疗反应,显示出对抗癌症的希望. 进一步的研究可能会导致基于这些天然生物分子的新型癌症疗法.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 运动生理学 运动生理学
背景情况:
- 癌症是一个重大的医疗挑战,推动了寻找新的治疗策略.
- 细胞外囊泡 (EVs),包括外体,是细胞间通信的关键媒介.
- 运动会影响生理过程并增加EV分泌,这表明它在健康和疾病中起着作用.
研究的目的:
- 审查运动衍生的细胞外囊泡 (EVs) 在癌症生物学中的新兴作用.
- 讨论EVs影响癌症进展和治疗的机制.
- 探索开发基于EV的癌症疗法的潜力.
主要方法:
- 审查临床前研究和有关运动,电动运动和癌症的现有文献.
- 对运动衍生的EVs的分子载荷和细胞间信号功能的分析.
- 检查EVs对瘤生长,转移和治疗反应的影响.
主要成果:
- 临床前研究表明,运动衍生的EV可以抑制瘤生长并减少动物模型中的转移.
- 运动诱导的EV已被证明可以通过使癌细胞敏感来提高化疗的疗效.
- 电动汽车携带生物活性分子,可以调解抗癌效应,促进更健康的生理状态.
结论:
- 运动衍生电动车为创新的癌症疗法提供了一个有前途的途径.
- 了解EV配置文件可能会导致炼模拟剂或向药物的开发.
- 需要进一步的研究来将临床前发现转化为癌症治疗的临床应用.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


